SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-18-100592
Filing Date
2018-03-29
Accepted
2018-03-29 08:02:20
Documents
70
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d498563d10k.htm 10-K 776128
2 EX-21.1 d498563dex211.htm EX-21.1 2195
3 EX-23.1 d498563dex231.htm EX-23.1 1954
4 EX-31.1 d498563dex311.htm EX-31.1 9231
5 EX-31.2 d498563dex312.htm EX-31.2 9240
6 EX-32.1 d498563dex321.htm EX-32.1 4020
7 EX-32.2 d498563dex322.htm EX-32.2 4002
  Complete submission text file 0001193125-18-100592.txt   5535316

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT galt-20171231.xml EX-101.INS 846537
9 XBRL TAXONOMY EXTENSION SCHEMA galt-20171231.xsd EX-101.SCH 72927
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20171231_cal.xml EX-101.CAL 49532
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20171231_def.xml EX-101.DEF 392847
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20171231_lab.xml EX-101.LAB 553455
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20171231_pre.xml EX-101.PRE 455811
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31791 | Film No.: 18720590
SIC: 2834 Pharmaceutical Preparations